Literature DB >> 6294441

A clinical and pathological study of diffuse type hepatocellular carcinoma.

K Okuda, T Noguchi, Y Kubo, Y Shimokawa, M Kojiro, T Nakashima.   

Abstract

Six autopsy cases of the rare, diffuse type of hepatocellular carcinoma (HCC), as classified gross anatomically according to the strict definition, have been studied. The prominent clinical feature was the rapid deterioration of the patient's general condition, terminating in hepatic failure. The liver size enlarged quickly, at a perceptible speed, often accompanied by abdominal pain. Diagnosis of this particular type of HCC was difficult, and celiac angiography and scintiscan of the liver were only suggestive when considered together with other laboratory data. Hepatitis B surface antigen was positive in all three patients in whom it was tested. The entire liver was studded with minute, uniformly sized tumor nodules, evenly distributed throughout. Some of them were grossly indistinguishable from cirrhotic nodules. All livers had an underlying cirrhosis which was characterized by relatively small regenerative nodules with thin stromas. Large portal branches at the hilum contained tumor thrombi in all patients, except for one case in which left lobectomy was followed by intraportal dissemination. Histologically, all tumor nodules represented intrahepatic metastases via the portal vein system. Tumor cells were poorly differentiated. These findings suggest that the diffuse type of HCC most frequently, if not always, represents intrahepatic, widespread portal metastases which have occurred within a short period of time.

Entities:  

Mesh:

Year:  1981        PMID: 6294441     DOI: 10.1111/j.1600-0676.1981.tb00044.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  11 in total

Review 1.  Infiltrating hepatocellular carcinoma: seeing the tree through the forest.

Authors:  Aram Demirjian; Peter Peng; Jean-Francois H Geschwind; David Cosgrove; Jacob Schutz; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2011-07-02       Impact factor: 3.452

2.  Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes.

Authors:  Peter J Kneuertz; Aram Demirjian; Amin Firoozmand; Celia Corona-Villalobos; Nikhil Bhagat; Joseph Herman; Andrew Cameron; Ahmet Gurakar; David Cosgrove; Michael A Choti; Jean-Francois H Geschwind; Ihab R Kamel; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2012-04-03       Impact factor: 5.344

3.  Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?

Authors:  Tsung-Hsing Hung; Chen-Chi Tsai; Chung-Chi Lin; Hsing-Feng Lee; Chi-Jen Chu; Han-Chieh Lin
Journal:  Hepatol Int       Date:  2012-07-27       Impact factor: 6.047

4.  Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma.

Authors:  Neil Mehta; Nicholas Fidelman; Monika Sarkar; Francis Y Yao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

5.  Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Jin Wook Chung; Eun Ju Cho; Su Jong Yu; Jeong-Hoon Lee; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-03       Impact factor: 4.553

6.  Diffuse-Type Hepatoma: A Grave Prognostic Marker.

Authors:  Rohan C Siriwardana; Chandika A H Liyanage; Bhagya Gunetilleke; Madunil A Niriella; Janaka de Silva; Anuradha S Dassanayake; Subani P Jayatunge
Journal:  Gastrointest Tumors       Date:  2017-03-16

7.  Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.

Authors:  Umberto Cillo; Alessandro Vitale; Marco Bassanello; Patrizia Boccagni; Alberto Brolese; Giacomo Zanus; Patrizia Burra; Stefano Fagiuoli; Fabio Farinati; Massimo Rugge; Davide Francesco D'Amico
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

8.  A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment.

Authors:  Yu-Tzu Liu; Tai-Chung Tseng; Ruey-Shyang Soong; Chun-Yi Peng; Yu-Hsing Cheng; Shiu-Feng Huang; Tsung-Hsien Chuang; Jia-Horng Kao; Li-Rung Huang
Journal:  J Immunother Cancer       Date:  2018-12-07       Impact factor: 13.751

9.  Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.

Authors:  Anıl Çolaklar; Namık Kemal Altınbaş
Journal:  J Ultrason       Date:  2020-03-31

Review 10.  Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Jelena Djokic Kovac; Tamara Milovanovic; Vladimir Dugalic; Igor Dumic
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.